Amplitude Ventures related stories
All articles and analysis
iNovia Capital approaches finish line with $150 mln Fund IVMontréal-based iNovia Capital, one of Canada’s best known venture firms, is only weeks away from wrapping up its fourth information technology fund, a source with knowledge of the matter told PE Hub Canada. Fund IV is targeted to raise $150 million in committed capital, which if reached will make the fund the largest raised to date by the firm.
White Star Capital collects $70 mln for initial fundWhite Star Capital has raised $70 million for its inaugural fund. The venture firm is planning on investing between $500,000 and $5 million into companies in North America and Europe. The fund's backers include sovereign and institutional funds supported by entrepreneurs and family offices from over 18 markets.
C100’s 48 Hours in the Valley selects December cohortThe C100 recently announced the names of Canadian startups selected to participate in the next 48 Hours in the Valley, the organization’s flagship program. On December 7-9 2015 http://www.thec100.org/events/ participating companies will engage in 2.5 days of programming, mentorship and networking in Silicon Valley. The 17 selected startups, which join some 200 alumni companies supported by C100 programs over the past five years, are: BONE Structure, CareGuide, Community Sift, CrowdRiff, Flatbook, Foko, Graphite Software, LoginRadius, MappedIn, PostBeyond, Roadmunk, Sensibill, Sharethebus, Statflo, Storybird, ThinkData Works and Vantage.
Top Canadian VC deals from the third quarterIn the coming weeks, the Canadian Venture Capital & Private Equity Association (CVCA) and Thomson Reuters will issue their reports on Canadian venture capital market activity in the third quarter of 2015. In the meantime, PE Hub Canada has compiled a list of the likely top 10 (disclosed) financings completed between July and September.
- Encycle Therapeutics raises $2.1 mln
Encycle Therapeutics Inc. said Wednesday it raised C$2.85 million (US$2.1 million) in financing led by Takeda Pharmaceutical Company Ltd. through its venture capital arm, Takeda Ventures Inc. Also participating were Accel-Rx Health Sciences Accelerator, BDC Capital and MaRS Investment Accelerator Fund. Encycle, a University of Toronto spin-off, is a drug discovery company.
Encycle Therapeutics nabs $2.85 mln in round led by Takeda VenturesToronto-based drug discovery startup Encycle Therapeutics Inc has closed $2.85 million in follow-on funding. The round was led by Takeda Ventures, the venture capital arm of Japan's Takeda Pharmaceutical Co Ltd, and was joined by Accel-Rx Health Sciences Accelerator, BDC Capital and MaRS Investment Accelerator Fund. Encycle said the deal's proceeds will support development of its nacellin platform chemistry and advance its pipeline of novel therapeutics. Encycle will also be supported in building on research collaborations and preparing for a Series A financing and/or strategic partnerships. Encycle raised $2.5 million from investors /canada/2014/11/11/encycle-therapeutics-raises-over-2-5-mln-to-advance-drug-platform/?utm_source=twitterfeed&utm_medium=twitter&utm_term=Canada+blog&utm_content=Canada+blog+posts last November.
- Canadian startup Encycle Therapeutics nabs C$2.85 mln
Toronto-based drug discovery company Encycle Therapeutics has closed C$2.85 million in funding. The investors were Takeda Ventures Inc, Accel-Rx Health Sciences Accelerator, BDC Capital and MaRS Investment Accelerator Fund. Encycle is a University of Toronto spin-out.
Canadian venture fundraising turns a corner with help from VCAPLatest data from the first half of 2015 show that the VCAP program, launched in 2013, has bolstered VC supply
Top Canadian VC deals from the second quarterIn the coming weeks, the Canadian Venture Capital & Private Equity Association (CVCA) and Thomson Reuters will issue their reports on Canadian venture capital market activity in the second quarter of 2015. In the meantime, peHUB Canada has compiled a list of the likely top 10 (disclosed) financings completed between April and June.
Espial buys VC-backed video solutions platform BluestreakEspial Group has acquired Bluestreak Technology Inc, a Montréal-based software and services provider of video solutions for connected devices, including set-top boxes, smart TVs, smartphones and tablets. The deal, the financial terms of which were not disclosed, includes the company's operations in Paris. Founded in 2002, Bluestreak has been backed by a number of Canadian and U.S. venture capital firms and other investors. They include BDC Capital, Entrepia Ventures, First Capital Group, the Fonds de solidarité FTQ, Iris Capital and Wellington Financial. With headquarters in Ottawa, Espial is supplier of digital TV and Internet protocol TV software and solutions.